Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tema Healthcare AI ETF (NQ:HLTH)

27.75 +0.60 (+2.22%)
Official Closing Price Updated: 4:15 PM EDT, Aug 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tema Healthcare AI ETF

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Cue Health's Growing Integrated Care Platform Of Lab-Quality Diagnostic Tests For Use At-Home And At The Point-of-Care Is Transforming How Healthcare Is Delivered ↗
Last month, the Food and Drug Administration (FDA) granted a landmark De Novo authorization for Cue Health’s (NASDAQ: HLTH) at-home COVID-19 test that 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Cue Health Becomes First Company to Receive FDA De Novo Authorization COVID-19 Home Use Test ↗
Cue Health Inc (NASDAQ: HLTH) became the first company to receive De Novo authorization from the FDA for its Cue COVID-19 Molecular Test, designed for both home and  
Via Benzinga
News headline image
Cue Health Achieves Groundbreaking Milestone with FDA: First Company to Receive De Novo Authorization for a COVID-19 Home Use Test
From Cue Health
Via Business Wire
News headline image
Expert Ratings for Cue Health ↗
 
Via Benzinga
News headline image
Recap: Cue Health Q1 Earnings ↗
 
Via Benzinga
News headline image
Earnings Preview: Cue Health ↗
 
Via Benzinga
News headline image
Cue Health Earnings Perspective: Return On Invested Capital ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  On Tuesday, 69 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  Monday's session saw 41 companies set new 52-week lows. 
Via Benzinga
News headline image
Cue Health's Earnings Outlook ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 2, 2023 ↗
 
Via Benzinga
News headline image
Cue Health to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
From Cue Health Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Cue Health Reports First Quarter 2023 Financial Results
From Cue Health Inc.
Via Business Wire
News headline image
Cue Health Makes De Novo Submission to FDA for Full Clearance of its Cue® RSV Molecular Test
From Cue Health
Via Business Wire
News headline image
Cue Health Launches Pharmacy Offering to Empower Individuals to Manage Common Health and Wellness Needs from Home
From Cue Health
Via Business Wire
News headline image
Why Tredegar Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers Trevena, Inc. (NASDAQ: TRVN) shares surged 170% to $1.74 after the company announced the approval of OLINVYK in China. 
Via Benzinga
News headline image
Cue Health to Announce First Quarter 2023 Financial Results
From Cue Health Inc.
Via Business Wire
News headline image
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Cue Health Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cue Health Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
Cue Health Receives FDA Emergency Use Authorization for Molecular Mpox Test
From Cue Health
Via Business Wire
News headline image
Cue Health Reports Fourth Quarter and Full-Year 2022 Financial Results
From Cue Health Inc.
Via Business Wire
News headline image
Earnings Scheduled For March 15, 2023 ↗
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million. 
Via Benzinga
News headline image
Cue Health’s New Suite of At-Home Diagnostic Tests and Expansion of Cue Care Puts You in Control of Your Health
From Cue Health
Via Business Wire
News headline image
Cue Health Collaborates with Pfizer to Provide People who Test Positive for COVID-19 with Actionable Health Information to Better Inform their Treatment Journey
From Cue Health
Via Business Wire
News headline image
Cue Health to Announce Fourth Quarter and Full-Year 2022 Financial Results
From Cue Health Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Cue Health to Participate at Upcoming Investor Conferences
From Cue Health Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.